Best in Biotech 2 Sep 2021The Top 15 Biotech Companies to Find in Amsterdam Known for its nightlife and the beauty of its canals, Amsterdam is also the home of many innovative companies within… September 2, 2021 - 7 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 23 Feb 2021European Cancer Deals Increasingly Focus on Natural Killer Cells Natural killer cells are becoming a hot topic in the booming cancer cell therapy scene, with the field’s latest big… February 23, 2021 - 6 minutesmins - By Kostas Vavitsas Share WhatsApp Twitter Linkedin Email
News and Trends 17 Dec 2020Covid-19 Leaves Lasting Impact on Hematology at ASH 2020 Conference Under the heavy shadow of the Covid-19 pandemic, last week’s annual conference of the American Society of Hematology (ASH) displayed… December 17, 2020 - 6 minutesmins - By Victor Kotsev Share WhatsApp Twitter Linkedin Email
News and Trends 3 Nov 2020Kiadis’ Natural Killer Cell Therapies Earn €308M Acquisition by Sanofi The French big pharma Sanofi has offered €308M to acquire the Dutch firm Kiadis Pharma and get hold of cancer… November 3, 2020 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 13 Jul 2020Sanofi Enlists Cell Therapy Firm Kiadis in €875M Immuno-Oncology Deal The Dutch biotech Kiadis Pharma has licensed an off-the-shelf cell therapy program to the pharma giant Sanofi for up to… July 13, 2020 - 3 minutesmins - By David Wilson Share WhatsApp Twitter Linkedin Email
News and Trends 13 Nov 2019Mass Layoffs as Dutch Biotech Cancels Phase III Cell Therapy Trial The Dutch company Kiadis Pharma has discontinued the development of a cell therapy in blood cancer, laid off half of… November 13, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 3 Jun 2019Dutch Company Raises €28M to Push Cancer Cell Therapy to European Market The Dutch Kiadis Pharma has raised €27.6M in a private placement to fund the clinical development of immune cell therapies… June 3, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
In Depth 23 Jan 2018Walking with the Dinosaurs of European Biotech: Which of Them is Roaring the Loudest? Although biotech may seem like an industry that has only just gotten started, it was already up and running before… January 23, 2018 - 10 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 4 Dec 2017Dutch Bone Marrow Transplant for Blood Cancer could get rid of Donor Matching Kiadis Pharma starts Phase III trials with ATIR101, a therapy that could make half-matched donors suitable for bone marrow transplant… December 4, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 20 Sep 2017Dutch Biotech Gets Special Designation for Reduced Risk Blood Cancer Treatment The FDA has backed Kiadis Pharma's lead blood cancer product by granting it the Regenerative Medicine Advanced Therapy designation. Kiadis Pharma,… September 20, 2017 - 2 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
Interview 22 May 2017Meet the New CEO of the Dutch Biotech Making a Cure for Blood Cancer Arthur Lahr, CEO of Kiadis Pharma, explains the promising cell therapy the company is developing and discusses how the dutch… May 22, 2017 - 7 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 26 Apr 2017BRIEF: Dutch Biotech Goes for MAA in the EU with new Immunotherapy Kiadis Pharma has applied for marketing authorization from the EMA for its T cell immune therapy, which could halt graft-versus-host… April 26, 2017 - 1 minutemin - By Melanie De Almeida Share WhatsApp Twitter Linkedin Email
News and Trends 15 Dec 2016Curing Cancer with Safer Transplants: UK Approval to start Clinical Trials Kiadis Pharma has received approval to test in the UK an immune therapy to address the big challenges of bone… December 15, 2016 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 6 Dec 2016How is European Immuno-Oncology fighting Blood Cancer? From leukemia to multiple myeloma, biotech is working hard to cure blood cancer. This year's edition of the American Society… December 6, 2016 - 4 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 28 May 2016It’s Blood Cancer Day, how is Biotech fixing it? Today is the World Blood Cancer Day, an event to show solidarity to patients and raise awareness for the need… May 28, 2016 - 4 minutesmins - By Denise Neves Gameiro Share WhatsApp Twitter Linkedin Email
News and Trends 15 Jan 2016Biotech of the week: Kiadis Pharma, Immuno-therapy made in Amsterdam This week we say 'auf Wiedersehen' to Germany and head West to the Netherlands and it's capital city, Amsterdam. This… January 15, 2016 - 2 minutesmins - By Philip Hemme Share WhatsApp Twitter Linkedin Email
News and Trends 10 Dec 2015Infographic: The Anatomy of European Biotech Which part of our body do European biotechs prefer to target? And how diversified are the biotech companies in Europe… December 10, 2015 - 1 minutemin - By Nicolas Sainte-Foie Share WhatsApp Twitter Linkedin Email
News and Trends 6 Jul 2015Kiadis launches its Cell-based Immunotherapies on European stock markets Kiadis Pharma has launched an IPO on Euronext Amsterdam and Euronext Brussels with the aim of raising €32.7M. The company… July 6, 2015 - 2 minutesmins - By Lourdes Riquelme Share WhatsApp Twitter Linkedin Email